LeMaitre Vascular
LMAT
183 hedge funds and large institutions have $928M invested in LeMaitre Vascular in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 65 reducing their positions, and 30 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 65
1.14% less ownership
Funds ownership: 85.99% → 84.85% (-1.1%)
6% less capital invested
Capital invested by funds: $989M → $928M (-$60.3M)
6% less funds holding
Funds holding: 195 → 183 (-12)
37% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 30
91% less call options, than puts
Call options by funds: $1M | Put options by funds: $10.7M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Millennium Management
New York
|
+$8.11M |
| 2 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$4.14M |
| 3 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
+$3.24M |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
+$2.23M |
| 5 |
JP Morgan Chase
New York
|
+$1.84M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.88M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.83M |
| 3 |
Morgan Stanley
New York
|
-$3.82M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.89M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.75M |
LMAT Hedge Fund Activity: Q4 2021 in Review
183 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2021, worth a combined $928M — down 6.1% from $989M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of LMAT and 19 opened new positions — a net loss of 11 holders — while 65 trimmed existing stakes and 67 added.
The largest buyer was Millennium Management, adding an estimated $8.11M. The largest seller was Goldman Sachs, cutting an estimated $3.88M.
- 183 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2021, down from 195 in Q3 2021.
- Funds reported $928M of LeMaitre Vascular stock for Q4 2021, down 6.1% quarter-over-quarter.
- 19 funds opened new LeMaitre Vascular positions in Q4 2021 and 30 closed out, a net change of -11 holders.
- The largest LeMaitre Vascular buyer in Q4 2021 was Millennium Management, an estimated $8.11M added.
- The largest LeMaitre Vascular seller in Q4 2021 was Goldman Sachs, an estimated $3.88M sold.
Based on aggregated 13F filings for Q4 2021.